IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Life Science Advisors, LLC

Q1 2025 Holdings

Filed 2025-05-14 | 13 holdings | $521.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kymera Therapeutics, Inc.(KYMR)Common Stock501575104$134.0M4,896,46225.7%
Disc Medicine, Inc.(IRON)Common Stock254604101$118.4M2,384,45622.7%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$95.5M9,130,46518.3%
Day One Biopharmaceuticals, Inc.(DAWN)Common Stock23954D109$51.0M6,430,2579.8%
Sionna Therapeutics, Inc.(SION)Common Stock829401108$38.6M3,694,0207.4%
Third Harmonic Bio, Inc.(THRD)Common Stock88427A107$36.1M10,402,2866.9%
Korro Bio, Inc.(KRRO)Common Stock500946108$19.8M1,137,1493.8%
Vigil Neuroscience, Inc.(VIGL)Common Stock92673K108$10.4M5,836,8742.0%
Ikena Oncology, Inc.Common Stock45175G108$6.4M5,018,1781.2%
Aerovate Therapeutics, Inc.Common Stock008064107$4.5M1,799,2320.9%
Q32 Bio, Inc.(QTTB)Common Stock746964105$3.5M2,092,1060.7%
Generation Bio, Co.(GBIOGBX)Common Stock37148K100$3.4M8,279,4840.6%
Spero Therapeutics, Inc.(SPRO)Common Stock84833T103$219.8K305,2550.0%